Literature DB >> 8998195

Impairment of acetylcholine relaxations by malondialdehyde, a marker of lipid peroxidation.

M A Rodríguez-Martínez1, J Martínez-Orgado, M Salaices, J Marín.   

Abstract

The effect of malondialdehyde (MDA), a lipid peroxidation marker, on the relaxations evoked by acetylcholine (ACh) was analyzed in tail arteries of Sprague-Dawley rats, which have MDA plasma levels of 0.43 +/- 0.10 microM. MDA (0.5-30 microM) produced an inhibition of ACh relaxations that persisted after repeated washing periods, and was independent of the incubation time. MDA did not modify the vasodilator responses to either exogenous nitric oxide (NO) or sodium nitroprusside, a NO donor. L-Arginine (the NO synthase substrate) did not prevent the impairment of relaxations to ACh caused by MDA. The association of N omega-nitro-L-arginine methyl ester (a NO synthase inhibitor) and MDA produced an additive inhibition of the ACh-induced relaxations. Superoxide dismutase (a superoxide anion scavenger) completely reversed the inhibitory effect of MDA. These results suggest: (1) MDA is not only a marker of lipid peroxidation but also an agent that can impair endothelium-dependent relaxations; (2) this impairment does not seem to be due to an interference with guanylate cyclase activation by NO or with NO synthase pathway; (3) the effect of MDA appears to be mediated by superoxide anion, and (4) MDA could propagate lipid peroxidation chain reactions in endothelial membranes, that could alter the function of muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8998195     DOI: 10.1159/000159185

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  4 in total

1.  Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.

Authors:  Sheng-Lan Wang; Xin-Yan Zhu; Dong-Wei Zhang; Zhao-Jie Zhang; Heng-Jun Gao; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

3.  Association of increased lipid peroxide levels in the aorta in comparison to the pulmonary artery with the presence of coronary artery disease.

Authors:  Abdul Rauoof Malik
Journal:  Biomed Rep       Date:  2016-02-25

Review 4.  From Microenvironment Remediation to Novel Anti-Cancer Strategy: The Emergence of Zero Valent Iron Nanoparticles.

Authors:  Ya-Na Wu; Li-Xing Yang; Pei-Wen Wang; Filip Braet; Dar-Bin Shieh
Journal:  Pharmaceutics       Date:  2022-01-02       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.